Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.
See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.
Pacific Edge is a publicy listed company on the NZX: listed as PEB.
- Value $00,000.000
- Volume 00,000
- Capitalisation $000,000
- Open $0.000
- Close $0.000
- High $0.000
- Low $0.000
Data up to date as of 00-00-0000 00:00
Pacific Edge 2017 Annual Meeting Results
Pacific Edge held its Annual Meeting in Dunedin on 24 August 2017, updating shareholders on its strategic progress, particularly in the US which is the company’s primary opportunity. A positive and supportive group of shareholders attended both in Dunedin and on-line utilising an interactive meeting platform. [read more]
Pacific Edge 2017 Annual Meeting to Take Place on 24 August
Pacific Edge is holding its Annual Shareholders' Meeting on 25 August at the Dunedin Public Art Gallery. For more information including Proxy Form, read on. [read more]
Cxbladder Test Suite Adopted by MidCentral DHB
Cancer diagnostics company, Pacific Edge has signed a commercial agreement with the MidCentral District Health Board (MCDHB) extending its use to the full suite of Cxbladder cancer tests for use across the clinical pathway for the detection, management and monitoring of bladder cancer patients. [read more]
Reports and Presentations
For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below
FY17 Full Year Results Conference Call Audio Commentary[5.8 MB]
FY17 Full Year Results Presentation[3.1 MB]